We are live on
!
Find out more
WSA
Wall Street Associates Portfolio holdings
AUM
$151M
1-Year Est. Return
30.3%
This Fund
S&P 500
This Quarter
Est. Return
+12.91%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
+$2.09M
(+0.2%)
Cap. Flow
-$58.5M
Cap. Flow
% of AUM
-5.52%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
379
New
57
Increased
31
Reduced
195
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Growth ETF
IWO
|
+$7.65M |
| 2 |
PGND
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
|
+$7.12M |
| 3 |
Sportsman's Warehouse
SPWH
|
+$7.09M |
| 4 |
Evolent Health
EVH
|
+$6.82M |
| 5 |
TACO
Del Taco Restaurants, Inc. Common Stock
TACO
|
+$5.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$32.7M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$13.3M |
| 3 |
VRTU
Virtusa Corporation
VRTU
|
+$9.09M |
| 4 |
Repligen
RGEN
|
+$8.82M |
| 5 |
El Pollo Loco
LOCO
|
+$7.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.16% |
| 2 | Technology | 23.34% |
| 3 | Consumer Discretionary | 14.42% |
| 4 | Industrials | 9.4% |
| 5 | Communication Services | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Thermo Fisher Scientific
TMO
$214B
| $1.04M | 0.1% |
8,000
| – | – |
|
202
Super Micro Computer
SMCI
$19B
| $1.03M | 0.1% |
349,960
-80,000
| -19% | -$263K |
|
|
ENTL
203
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $1.03M | 0.1% |
40,000
| – | – |
|
|
CMRX
204
DELISTED
Chimerix, Inc.
CMRX
| $1.01M | 0.1% |
+21,843
| New | +$876K |
|
205
Incyte
INCY
$24B
| $997K | 0.09% |
9,572
-2,404
| -20% | -$249K |
|
|
CKEC
206
DELISTED
Carmike Cinemas Inc
CKEC
| $995K | 0.09% |
37,473
+15,372
| +70% | +$455K |
|
207
Old Dominion Freight Line
ODFL
$43.8B
| $991K | 0.09% |
43,341
-9,600
| -18% | -$228K |
|
208
PRA Group
PRAA
$692M
| $981K | 0.09% |
+15,740
| New | +$907K |
|
209
Affiliated Managers Group
AMG
$9.83B
| $969K | 0.09% |
4,431
-801
| -15% | -$178K |
|
210
J&J Snack Foods
JJSF
$1.71B
| $950K | 0.09% |
8,584
-2,400
| -22% | -$260K |
|
|
DYAX
211
DELISTED
DYAX CORPORATION
DYAX
| $949K | 0.09% |
+35,812
| New | +$949K |
|
212
BioCryst Pharmaceuticals
BCRX
$2.38B
| $942K | 0.09% |
+63,069
| New | +$717K |
|
|
UTIW
213
DELISTED
UTI WORLDWIDE INC
UTIW
| $933K | 0.09% |
93,397
-25,900
| -22% | -$250K |
|
|
DRII
214
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $931K | 0.09% |
29,514
-8,300
| -22% | -$271K |
|
|
AZPN
215
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $929K | 0.09% |
20,395
-4,000
| -16% | -$182K |
|
216
Neurocrine Biosciences
NBIX
$16.2B
| $920K | 0.09% |
+19,262
| New | +$817K |
|
217
Martin Marietta Materials
MLM
$32.3B
| $919K | 0.09% |
6,495
-200
| -3% | -$29.2K |
|
|
SIVB
218
DELISTED
SVB Financial Group
SIVB
| $914K | 0.09% |
6,348
-181
| -3% | -$24.5K |
|
219
BioMarin Pharmaceuticals
BMRN
$11.9B
| $898K | 0.08% |
6,563
-2,103
| -24% | -$261K |
|
220
Illumina
ILMN
$29.3B
| $897K | 0.08% |
4,223
-206
| -5% | -$40.2K |
|
221
Middleby
MIDD
$6.03B
| $892K | 0.08% |
7,947
+3,775
| +90% | +$404K |
|
222
Trex
TREX
$4.93B
| $890K | 0.08% |
72,000
| – | – |
|
|
MDCO
223
DELISTED
Medicines Co
MDCO
| $883K | 0.08% |
+30,859
| New | +$860K |
|
|
RLYP
224
DELISTED
RELYPSA INC COM
RLYP
| $870K | 0.08% |
+26,296
| New | +$904K |
|
225
Under Armour
UAA
$2.73B
| $834K | 0.08% |
20,000
| – | – |
|
Similar funds
CF
VWM
HH
NSCP
EEG
BC
WRHAM
SRP
Wall Street Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Wall Street Associates held 379 positions worth $1.06B, up 0.2% from $1.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Wall Street Associates withdrew a net $58.5M in Q2 2015, closing 48 positions and reducing 195 holdings. Its most notable exit was AUSPEX PHARMACEUTICALS INC COM STK (DE), an estimated $32.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Wall Street Associates opened a new position in iShares Russell 2000 Growth ETF worth $7.71M.
- Wall Street Associates's largest Q2 2015 buy was iShares Russell 2000 Growth ETF: 49,900 shares worth $7.71M.
- Wall Street Associates added most to Marcus & Millichap in Q2 2015, an estimated $3.39M increase.
- Wall Street Associates's biggest Q2 2015 reduction was Repligen, cutting an estimated $8.82M.
- Wall Street Associates fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $32.7M.
- Wall Street Associates's ten largest holdings make up 17% of its $1.06B portfolio in Q2 2015.
- Wall Street Associates opened 57 new positions and closed 48 in Q2 2015.
- Wall Street Associates's portfolio value rose 0.2% quarter-over-quarter to $1.06B.
Based on Wall Street Associates's 13F filing for Q2 2015, filed 13 Aug 2015.